Clinical Trial Update: ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

The document describes an ongoing Phase 2 study ARTEMIS-006 (HS-20093) for head and neck squamous cell carcinoma and other solid tumors. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING